Taylor, Cottrill, Erickson & Associates, Inc. Novartis Ag Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$340 Million
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$79.7 - $88.13 $2.01 Million - $2.22 Million	-25,222 Closed	0 $0
Q3 2021 Oct 15, 2021	SELL	$81.78 - $95.14 $69,513 - $80,869	-850 Reduced 3.26%	25,222 $2.06 Million
Q2 2021 Jul 20, 2021	SELL	$85.24 - $94.15 $31,964 - $35,306	-375 Reduced 1.42%	26,072 $2.38 Million
Q1 2021 Apr 14, 2021	SELL	$83.5 - $98.47 $29,225 - $34,464	-350 Reduced 1.31%	26,447 $2.26 Million
Q4 2020 Jan 25, 2021	SELL	$78.07 - $94.43 $167,850 - $203,024	-2,150 Reduced 7.43%	26,797 $2.53 Million

Q2 2020 Jul 14, 2020	SELL	$80.93 - $91.1 $12,139 - $13,665	-150 Reduced 0.52%	28,947 $2.53 Million
Q1 2020 Apr 15, 2020	SELL	$70.67 - $99.01 $159,007 - $222,772	-2,250 Reduced 7.18%	29,097 $2.4 Million
Q4 2019 Jan 14, 2020	SELL	$84.35 - $95.37 $10,543 - $11,921	-125 Reduced 0.4%	31,347 $2.97 Million
Q3 2019 Oct 25, 2019	SELL	$85.54 - $94.26 $46,448 - $51,183	-543 Reduced 1.7%	31,472 $2.74 Million
Q2 2019 Jul 26, 2019	SELL	$75.4 - $92.8 $509,779 - $627,420	-6,761 Reduced 17.44%	32,015 $2.92 Million
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $257,594 - $294,633	-3,420 Reduced 8.11%	38,776 $3.73 Million
Q4 2018 Jan 29, 2019	SELL	$73.66 - $82.02 $34,988 - $38,959	-475 Reduced 1.11%	42,196 $3.62 Million
Q3 2018 Oct 24, 2018	BUY	$66.94 - $77.43 $334 - $387	5 Added 0.01%	42,671 $3.68 Million
Q2 2018 Jul 30, 2018	BUY	$64.91 - $73.36 $9,736 - $11,004	150 Added 0.35%	42,666 $3.22 Million
Q1 2018 Apr 23, 2018	BUY	$70.39 - $84.15 $15,485 - $18,513	220 Added 0.52%	42,516 $3.44 Million
Q4 2017 Jan 24, 2018	SELL	$72.33 - $77.64 $71,968 - $77,251	-995 Reduced 2.3%	42,296 $3.55 Million
Q3 2017 Oct 19, 2017	BUY	$74.14 - $77.27 $3.21 Million - $3.35 Million	43,291	43,291 $3.72 Million

Others Institutions Holding NVS

# of Institutions

1,352

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $236B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account